Wellcare 2023 Formulary Changes
Date: 11/07/22
On January 1, 2023, some drugs will no longer be covered on our Medicare Part D Plan formulary(ies). To assist our providers, we have included the list below of the most commonly prescribed drugs being removed along with the drug’s 2023 formulary alternative(s).
Product Name | Formulary Alternative |
---|---|
OZEMPIC INJ 2/1.5ML (1MG/DOSE) | OZEMPIC INJ 2MG/1.5ML (0.25 OR 0.5MG/DOSE), OZEMPIC INJ 4MG/3ML (1MG/DOSE), OZEMPIC INJ 8MG/ML (2MG/DOSE) - NEW |
TIMOLOL MAL SOL 0.5% (generic for once daily Istalol) | TIMOLOL MAL SOL 0.25%, 0.5% (generic for twice daily Timoptic), TIMOLOL GEL SOL 0.25%, 0.5% (generic for once daily Timoptic-XE gel sol) |
If you determine that it is necessary for your patient to continue to receive the non-formulary drug in 2023, you will need to submit a Coverage Determination request on or after November 1, 2022.
Request forms are located on our website on the Coverage Determinations and Redeterminations for Drugs page at www.Wellcare.com/healthnetOR and www.Wellcare.com/trilliumOR or you can call to request authorization.
If you have any questions, please contact Medicare Pharmacy Services at 1-800-867-6564.